Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04098276 · ClinicalTrials.gov registry record · NA

It's WeWomen Plus Intervention for Health, Safety and Empowerment

A NA study of Violence and Violence, Domestic, sponsored by Johns Hopkins University.

Completed
Registry status
NA
Development phase
1,265
Enrollment target
1
Study location

NCT04098276 is a NA study of Violence and Violence, Domestic that has completed, run by Johns Hopkins University. The registered enrollment target is 1,265 participants, below the 4,471-participant average among 19 other Violence trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04098276, a NA study of Violence and Violence, Domestic, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
NA
Development phase
1,265 participants
Enrollment target
1
Study location

Study Summary

This study evaluates the impact of adaptive technology-based intervention (online, text and phone) "weWomenPlus" on safety, mental health and empowerment of abused immigrant women.

Interventions

  • BEHAVIORAL WeWomen Plus technology based intervention

Study Locations (1)

Maryland

  • Johns Hopkins University - Baltimore

Trial Details

FieldValue
Enrollment Target 1,265 participants
Start Date 2021-01-11
Est. Completion 2024-07-29
Phase NA

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT04098276

The ClinicalTrials.gov registry entry for NCT04098276 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,265 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,471-participant average among 19 other Violence trials with a reported enrollment target (72% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Violence appearing as the primary indexed condition, and to 1 intervention - of which WeWomen Plus technology based intervention is the first listed.

NCT04098276 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT04098276 about?

NCT04098276 is a clinical study titled "It's WeWomen Plus Intervention for Health, Safety and Empowerment". This study evaluates the impact of adaptive technology-based intervention (online, text and phone) "weWomenPlus" on safety, mental health and empowerment of abused immigrant women.

What is the current status of trial NCT04098276?

This trial is currently completed. It is a NA study. The enrollment target is 1,265 participants. The study started on 2021-01-11. Estimated completion is 2024-07-29.

What conditions does trial NCT04098276 study?

This clinical trial studies the following conditions: Violence, Violence, Domestic, Violence, Physical, Violence, Sexual, Violence, Gender-Based.

What interventions are being tested in trial NCT04098276?

The interventions under investigation include: WeWomen Plus technology based intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT04098276?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04098276 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Violence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.